Pacira BioSciences, Inc. (PCRX) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for…
Source: Yahoo Finance
Sector & Industry
Pacira BioSciences, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Pacira BioSciences, Inc. at a Glance
| Company | Pacira BioSciences, Inc. |
| Ticker | PCRX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $26.35 |
| Market cap | $1.05B |
| P/E ratio (trailing) | 75.29 |
| EPS (trailing) | $0.35 |
| 52-week high | $27.66 |
| 52-week low | $18.80 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.27 |
| Return on equity (ROE) | 2.05% |
| Debt-to-equity | 61.33% |
| Average volume | 562,638 |
| Shares outstanding | 39.86M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 825 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Pacira BioSciences, Inc.'s current P/E ratio?
- Pacira BioSciences, Inc. (PCRX) has a trailing P/E ratio of 75.29 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Pacira BioSciences, Inc.'s market capitalisation?
- Pacira BioSciences, Inc.'s market cap is $1.05B based on our latest snapshot. See how it ranks by market cap →
- What is PCRX's 52-week range?
- Over the past 52 weeks, PCRX has traded between $18.80 and $27.66. What does the 52-week range mean? →
- How volatile is Pacira BioSciences, Inc. compared to the market?
- Pacira BioSciences, Inc. has a beta of 0.27, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Pacira BioSciences, Inc. pay a dividend?
- Pacira BioSciences, Inc. does not currently pay a dividend according to our latest data.
- What exchange is PCRX listed on?
- PCRX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Pacira BioSciences, Inc. in?
- Pacira BioSciences, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →